Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Name:	us-gaap_RevenueFromGrants
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Note 8 - Government Grants (Details) (USD $)	3 Months Ended		6 Months Ended		1 Months Ended	23 Months Ended		1 Months Ended	3 Months Ended		6 Months Ended
Note 8 - Government Grants (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jul. 31, 2014 Subsequent Event [Member] SBIR Grant [Member]	Aug. 31, 2012 First NIH Grant [Member]	Jun. 30, 2014 First NIH Grant [Member]	Jul. 31, 2013 SBIR Grant [Member]	Jun. 30, 2014 NIH Grants [Member]	Jun. 30, 2013 NIH Grants [Member]	Jun. 30, 2014 NIH Grants [Member]	Jun. 30, 2013 NIH Grants [Member]
Note 8 - Government Grants (Details) [Line Items]
Grant Award					$ 290,000	$ 20,400,000		$ 277,000
Unused Grant Funds							484,499
Revenue from Grants	$ 180,441	$ 441,561	$ 337,781	$ 1,238,601					$ 180,441	$ 441,561	$ 337,781	$ 1,238,601